Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America
about
Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America
description
clinical trial
@en
klinisch onderzoek
@nl
name
Assessing the Efficacy and Tol ...... y (COMBIGAN®) in Latin America
@en
type
label
Assessing the Efficacy and Tol ...... y (COMBIGAN®) in Latin America
@en
prefLabel
Assessing the Efficacy and Tol ...... y (COMBIGAN®) in Latin America
@en
P1050
P1476
Assessing the Efficacy and Tol ...... y (COMBIGAN®) in Latin America
@en
P3098
NCT01518244
P4844
P580
2011-12-01T00:00:00Z
P582
2013-02-01T00:00:00Z